By Adria Calatayud Germany's Merck KGaA has entered into a partnership to license a cancer drug developed by China's Jiangsu Hengrui Pharmaceuticals for up.
By Adria Calatayud Shares of Germany's Merck KGaA rose after the company forecast a return to organic sales growth next year, supported by recovering demand.
Health-care companies fell, but not by as much as the broad market, as traders rotated into defensive sectors. Pfizer shares declined after the Big Pharma.
By David Sachs Merck KGaA said that it has partnered with BenevolentAI and Exscientia on an initiative to discover more drugs with artificial intelligence,.